Stock VLA VIRALYTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Viralytics Ltd.

Equities

VLA

AU000000VLA6

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million
RE
Viralytics : Chairman’s letter to shareholders
PU
Viralytics : New Data Presented at SITC Annual Meeting
PU
Viralytics : Annual Report and Full Year Financial Results
PU
Viralytics : Newsletter
PU
Viralytics : Positive Bio-Marker Data from CANON Study
PU
Viralytics : Update on MITCI and KEYNOTE 200 trials at ASCO Ann Meeting
PU
Viralytics : Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial
PU
Viralytics : CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study
PU
Viralytics : Promising Results in CAPRA Trial of CAVATAK® in Combination with KEYTRUDA® in Melanoma Patients
PU
Viralytics : Edison Report – Cavatak combo data at AACR next month
PU
Viralytics : ASX Release – Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017
PU
Viralytics : Receives $4.3 Million R&D Tax Incentive
PU
Viralytics : Promising Advanced Melanoma Results from KEYTRUDA Combination Trial announced at SITC
PU
Viralytics : Dr Malcolm McColl on ABC TV's The Business
PU
Edison: Eye-catching MITCI Data
PU
Viralytics : Further Promising Data at AACR Meeting
PU
Viralytics : Clinical Results at Two Major Conferences
PU
Viralytics : Bioshares Top Six Stock Picks for 2016
PU
Viralytics : Completes $28 million Placement – SPP to Followm
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VLA Stock
  4. News Viralytics Ltd.